Randy H Thurman - Net Worth and Insider Trading

Randy H Thurman Net Worth

The estimated net worth of Randy H Thurman is at least $460,979 dollars as of 2024-03-29. Randy H Thurman is the Director of Veradigm Inc and owns about 58,905 shares of Veradigm Inc (MDRX) stock worth over $453,569. Randy H Thurman is the Director of Outlook Therapeutics Inc and owns about 594 shares of Outlook Therapeutics Inc (OTLK) stock worth over $7,092. Randy H Thurman is also the Executive Chairman of Presbia PLC and owns about 21,229 shares of Presbia PLC (LENSF) stock worth over $318. Besides these, Randy H Thurman also holds Arno Therapeutics Inc (ARNI) , TFF Pharmaceuticals Inc (TFFP) . Details can be seen in Randy H Thurman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Randy H Thurman has not made any transactions after 2022-09-29 and currently still holds the listed stock(s).

Transaction Summary of Randy H Thurman

To

Randy H Thurman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Randy H Thurman owns 6 companies in total, including Outlook Therapeutics Inc () , TFF Pharmaceuticals Inc () , and Veradigm Inc () among others .

Click here to see the complete history of Randy H Thurman’s form 4 insider trades.

Insider Ownership Summary of Randy H Thurman

Ticker Comapny Transaction Date Type of Owner
Outlook Therapeutics Inc 2020-09-14 director
TFF Pharmaceuticals Inc 2022-09-29 director
Veradigm Inc 2014-11-11 director
Presbia PLC 2017-03-13 director & Executive Chairman
Arno Therapeutics Inc 2014-01-24 director
Orthofix Medical Inc 2013-11-05 director

Randy H Thurman Latest Holdings Summary

Randy H Thurman currently owns a total of 5 stocks. Among these stocks, Randy H Thurman owns 58,905 shares of Veradigm Inc (MDRX) as of November 11, 2014, with a value of $453,569 and a weighting of 98.39%. Randy H Thurman owns 594 shares of Outlook Therapeutics Inc (OTLK) as of September 14, 2020, with a value of $7,092 and a weighting of 1.54%. Randy H Thurman also owns 21,229 shares of Presbia PLC (LENSF) as of November 25, 2015, with a value of $318 and a weighting of 0.07%. The other 2 stocks Arno Therapeutics Inc (ARNI) , TFF Pharmaceuticals Inc (TFFP) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Randy H Thurman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MDRX Veradigm Inc 2014-11-11 58,905 7.70 453,569
OTLK Outlook Therapeutics Inc 2020-09-14 594 11.94 7,092
LENSF Presbia PLC 2015-11-25 21,229 0.02 318
ARNI Arno Therapeutics Inc 2013-05-22 1,250 0.00 0
TFFP TFF Pharmaceuticals Inc 2022-09-29 0 6.04 0

Holding Weightings of Randy H Thurman


Randy H Thurman Form 4 Trading Tracker

According to the SEC Form 4 filings, Randy H Thurman has made a total of 0 transactions in Veradigm Inc (MDRX) over the past 5 years. The most-recent trade in Veradigm Inc is the acquisition of 8,849 shares on November 11, 2014, which cost Randy H Thurman around $99,905.

According to the SEC Form 4 filings, Randy H Thurman has made a total of 1 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Outlook Therapeutics Inc is the acquisition of 500 shares on September 14, 2020, which cost Randy H Thurman around $6,200.

According to the SEC Form 4 filings, Randy H Thurman has made a total of 0 transactions in Presbia PLC (LENSF) over the past 5 years. The most-recent trade in Presbia PLC is the acquisition of 1,833 shares on November 25, 2015, which cost Randy H Thurman around $9,990.

More details on Randy H Thurman's insider transactions can be found in the Insider Trading History of Randy H Thurman table.

Insider Trading History of Randy H Thurman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Randy H Thurman Trading Performance

GuruFocus tracks the stock performance after each of Randy H Thurman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Randy H Thurman is 6.45%. GuruFocus also compares Randy H Thurman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Randy H Thurman within 3 months outperforms 4 times out of 9 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Randy H Thurman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Randy H Thurman

Average Relative Return

35.15%

Average relative return per transaction

Outperforming Transactions

44%

4 out of 9 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 5.14 6.45 13.25 35.15 -21.28 -26.69
Relative Return to S&P 500(%) 3.53 2.44 5.99 22.57 -32.89 -37.21

Randy H Thurman Ownership Network

Ownership Network List of Randy H Thurman

No Data

Ownership Network Relation of Randy H Thurman


Randy H Thurman Owned Company Details

What does Outlook Therapeutics Inc do?

Who are the key executives at Outlook Therapeutics Inc?

Randy H Thurman is the director of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include Chief Commercial Officer Jeff Evanson , Chief Operating Officer Terry Dagnon , and director & CEO and President Trenary C Russell Iii .

Outlook Therapeutics Inc () Insider Trades Summary

Over the past 18 months, Randy H Thurman made no insider transaction in Outlook Therapeutics Inc (). Other recent insider transactions involving Outlook Therapeutics Inc () include a net sale of 368,671 shares made by Jeff Evanson , a net purchase of 200,000 shares made by Kurt J Hilzinger , and a net sale of 520,000 shares made by Terry Dagnon .

In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc () in total and bought 3,124 shares, with a net purchase of 3,124 shares. During the past 18 months, 47,558 shares of Outlook Therapeutics Inc () were sold and 16,291 shares were bought by its insiders, resulting in a net sale of 31,266 shares.

Outlook Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Outlook Therapeutics Inc Insider Transactions

No Available Data

Randy H Thurman Mailing Address

Above is the net worth, insider trading, and ownership report for Randy H Thurman. You might contact Randy H Thurman via mailing address: 222 Merchandise Mart Plaza, Suite 2024, Chicago Il 60654.

Discussions on Randy H Thurman

No discussions yet.